What is the registration number for CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET?

CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET is registered under USPTO registration number 4033261.

CLA

USPTO Trademark Record

ABANDONED

CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET

Q: Who owns the CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET trademark?

The CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET trademark is owned by IPSEN PHARMA S.A.S..

Q: What class is the CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET trademark registered in?

The CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET trademark is registered in Class 042 (Scientific, technology & SaaS services).

Q: What is the serial number for CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET?

The USPTO serial number for CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET is 79080475.

SN 79080475·Reg 4033261·Filed Feb 15, 2010

Owner IPSEN PHARMA S.A.S.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET (Serial No. 79080475), Registration No. 4033261, is a abandoned US trademark filed on Feb 15, 2010 by IPSEN PHARMA S.A.S.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET (Reg. #4033261) is an abandoned US trademark that was filed in 2010 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 7 opposition proceedings during prosecution.

FILED

Feb 15, 2010

SERIAL

79080475

REG#

4033261

REGISTERED

Oct 04, 2011

Owner

Applicant

IPSEN PHARMA S.A.S.

Entity

Not Provided

Address

65 quai Georges Gorse, F-92100 BOULOGNE BILLANCOURT

Country

Attorney

NameWilliam S. Frommer & Marilyn M. Brogan

Law firm

William S. Frommer & Marilyn M. Brogan HAUG PARTNERS LLP

Docket

452301-8066

Address

745 Fifth Avenue, NEW YORK, NY 10151, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateFeb 15, 2010

Serial Number79080475

Registration No.4033261

Registration DateOct 04, 2011

Status DateFeb 16, 2020

Published for OppositionFeb 08, 2011

Mark TypeStandard characters

Attorney Docket452301-8066

Status DescriptionUS registration is dead and cancelled

Filing Signals

FILED

2010

YEARS AGO

16y

CLASSES

MADRID FILINGS

—

Opposed 7× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

40 events

DEATH OF INTERNATIONAL REGISTRATION

Sep 04, 2020

DEATH OF INTERNATIONAL REGISTRATION

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Sep 04, 2020

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

TOTAL INVALIDATION PROCESSED BY THE IB

Mar 08, 2019

TOTAL INVALIDATION PROCESSED BY THE IB

INVALIDATION PROCESSED

Jan 25, 2019

INVALIDATION PROCESSED

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Jan 25, 2019

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

Jan 11, 2019

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

CANCELLED SECTION 71

May 11, 2018

CANCELLED SECTION 71

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 09, 2017

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 09, 2017

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 01, 2017

TEAS CHANGE OF CORRESPONDENCE RECEIVED

FINAL DECISION TRANSACTION PROCESSED BY IB

Apr 08, 2013

FINAL DECISION TRANSACTION PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

May 25, 2012

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Mar 12, 2012

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Mar 12, 2012

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jan 04, 2012

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Oct 04, 2011

REGISTERED-PRINCIPAL REGISTER

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Sep 14, 2011

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Sep 14, 2011

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

Aug 23, 2011

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

EXTENSION OF TIME TO OPPOSE RECEIVED

Mar 09, 2011

EXTENSION OF TIME TO OPPOSE RECEIVED

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Feb 19, 2011

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

PUBLISHED FOR OPPOSITION

Feb 08, 2011

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 08, 2011

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Feb 03, 2011

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Feb 03, 2011

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

LAW OFFICE PUBLICATION REVIEW COMPLETED

Jan 05, 2011

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 20, 2010

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Dec 10, 2010

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 10, 2010

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 10, 2010

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 23, 2010

TEAS RESPONSE TO OFFICE ACTION RECEIVED

REFUSAL PROCESSED BY IB

Jun 26, 2010

REFUSAL PROCESSED BY IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

May 25, 2010

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

REFUSAL PROCESSED BY MPU

May 25, 2010

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

May 25, 2010

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION WRITTEN

May 24, 2010

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

May 18, 2010

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Apr 13, 2010

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 09, 2010

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Apr 08, 2010

SN ASSIGNED FOR SECT 66A APPL FROM IB

CLARINET CONTROLLED STUDY OF LANREOTIDE ANTIPROLIFERATIVE RESPONSE IN NET

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by IPSEN PHARMA S.A.S.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by William S. Frommer & Marilyn M. Brogan

Resources

Company